title: Predictive factors for return of erectile function in robotic radical prostatectomy: case series from a single centre.
abstract: Postprostatectomy erectile dysfunction is a frequent complication of robotic-assisted radical prostatectomy (RARP). We attempted to retrospectively identify objective predictors of erectile recovery in a population of potent men undergoing RARP. Data for 375 consecutive patients were collected prospectively from a single surgeon in an academic institution from 2005 to 2011. Inclusion criteria were 2 years of complete follow-up, preoperative International Index of Erectile Function (IIEF) scores of ≥ 22 without erectogenic aids and no adjuvant therapy (n = 86). Patients were grouped by erectile function at 2 years as 'Recovery' (IIEF ≥ 17, n = 41) and 'non-recovery' (IIEF < 16, n = 45). Baseline and perioperative characteristics were evaluated between groups. Body mass index, operative time and gland volumes were not different between groups. Univariate analysis demonstrated that higher preoperative prostate-specific antigen, longer apical dissection time and non-nerve-sparing surgery decreased erectile recovery. Multivariable analysis demonstrated that longer apical dissection time remained an independent predictor of decreased erectile function (P < 0.001). In contrast, postoperative intracavernosal injection (ICI) was found to predict erectile recovery (P = 0.017). At 2-year follow-up, prolonged apical dissection time predicts nonrecovery and ICI rehabilitation predicts recovery of erectile function after RARP. This can inform patients' postoperative expectations. However, further studies are needed to support the findings of this exploratory analysis.
authors.affiliation: 1] Schulich School of Medicine and Dentistry, Western University, London, ON, Canada [2] St Joseph's Health Care, London, ON, Canada.
authors.forename: F J
authors.identifier: 0000000262098731
authors.initials: FJ
authors.lastname: Garcia
authors.affiliation: 1] Schulich School of Medicine and Dentistry, Western University, London, ON, Canada [2] St Joseph's Health Care, London, ON, Canada.
authors.forename: P D
authors.initials: PD
authors.lastname: Violette
authors.affiliation: St Joseph's Health Care, London, ON, Canada.
authors.forename: G B
authors.initials: GB
authors.lastname: Brock
authors.affiliation: St Joseph's Health Care, London, ON, Canada.
authors.forename: S E
authors.initials: SE
authors.lastname: Pautler
mesh_terms: D007172:Erectile Dysfunction / Q000209:etiology* / Q000534:rehabilitation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010410:Penile Erection; D010413:Penis / Q000294:innervation; D011468:Prostatectomy / Q000009:adverse effects* / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery; D020127:Recovery of Function; D012189:Retrospective Studies; D065287:Robotic Surgical Procedures / Q000009:adverse effects*; D016896:Treatment Outcome
references.citation: J Urol. 2005 May;173(5):1673-6
references.pmid: 15821546
references.citation: J Urol. 2003 Mar;169(3):1175-9
references.pmid: 12576876
references.citation: Eur Urol. 2012 Sep;62(3):418-30
references.pmid: 22749850
references.citation: J Endourol. 2013 Nov;27(11):1411-6
references.pmid: 23514580
references.citation: Eur Urol. 2006 Jun;49(6):1065-73; discussion 1073-4
references.pmid: 16597485
references.citation: Int J Impot Res. 1998 Jun;10(2):113-20
references.pmid: 9647948
references.citation: BJU Int. 2012 Aug;110(3):422-6
references.pmid: 22182202
references.citation: J Urol. 2010 Nov;184(5):2197-204
references.pmid: 20851436
references.citation: Eur Urol. 2011 May;59(5):702-7
references.pmid: 21296482
references.citation: BJU Int. 2008 Apr;101(8):1013-8
references.pmid: 18261153
references.citation: J Androl. 2003 Mar-Apr;24(2):239-45
references.pmid: 12634311
references.citation: Eur Urol. 2012 Aug;62(2):261-72
references.pmid: 22575909
references.citation: Eur Urol. 2009 May;55(5):1037-63
references.pmid: 19185977
references.citation: Can Urol Assoc J. 2013 Sep-Oct;7(9-10):333-4
references.pmid: 24319512
references.citation: Urology. 2002 Nov;60(5):864-8
references.pmid: 12429317
references.citation: Eur Urol. 2012 Apr;61(4):796-802
references.pmid: 22230713
references.citation: Curr Opin Urol. 2010 May;20(3):234-40
references.pmid: 20224415
references.citation: J Sex Med. 2011 Jan;8(1):255-60
references.pmid: 20727065
references.citation: Prostate. 1983;4(5):473-85
references.pmid: 6889192
references.citation: Jpn J Clin Oncol. 2004 Aug;34(8):463-8
references.pmid: 15371464
references.citation: Eur Urol. 2012 Mar;61(3):541-8
references.pmid: 22153926
references.citation: J Endourol. 2010 Feb;24(2):261-6
references.pmid: 20073551
references.citation: Can Urol Assoc J. 2007 Jun;1(2):97-101
references.pmid: 18542770
references.citation: Urology. 2012 Mar;79(3):596-600
references.pmid: 22386406
references.citation: J Urol. 2008 Jun;179(6):2207-10; discussion 2210-1
references.pmid: 18423693
references.citation: BJU Int. 2008 May;101(10):1217-22
references.pmid: 18279446
references.citation: Eur Urol. 2012 Jun;61(6):1222-8
references.pmid: 22425427
references.citation: JAMA. 2011 Sep 21;306(11):1205-14
references.pmid: 21934053
references.citation: Int J Impot Res. 1999 Dec;11(6):319-26
references.pmid: 10637462
references.citation: J Sex Med. 2013 Jan;10(1):195-203
references.pmid: 22970890
references.citation: Urology. 1997 Jun;49(6):822-30
references.pmid: 9187685